Appen (ASX:APX) Full Year 2024 Results
Key Financial Results
- Revenue: US$235.2m (down 14% from FY 2023).
- Net loss: US$20.0m (loss narrowed by 83% from FY 2023).
- US$0.087 loss per share (improved from US$0.83 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Appen Revenues and Earnings Beat Expectations
Revenue exceeded analyst estimates by 2.4%. Earnings per share (EPS) also surpassed analyst estimates by 16%.
The primary driver behind last 12 months revenue was the Global Services segment contributing a total revenue of US$118.1m (50% of total revenue). Notably, cost of sales worth US$197.4m amounted to 84% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to US$25.7m (44% of total expenses). Explore how APX's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 15% growth forecast for the IT industry in Australia.
Performance of the Australian IT industry.
The company's shares are down 44% from a week ago.
Risk Analysis
It's still necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Appen, and understanding them should be part of your investment process.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About ASX:APX
Appen
Operates as an AI lifecycle company that provides data sourcing, data annotation, and model evaluation solutions in Australia, the United States, and internationally.
Flawless balance sheet and undervalued.
Similar Companies
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Adobe: A Probabilistic Case for Undervaluation

A Capital Allocation Favorite with Structural Importance

Good foundation, but now it's all about the next steps
Recently Updated Narratives

Nilai Wajar di Tengah Pemulihan Kinerja

Making sense of 1.75 trillion IPO

Heliostar Metals, From 50k to 500k oz Producer Monster by 2030?
Popular Narratives

Investment Analysis (May 2026)

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

